How do the capabilities of NGS compare to hot spot testing, and why is whole exome sequencing based on hot spot panels preferred in the setting of precision oncology practice? (Korean)

How do the capabilities of NGS compare to hot spot testing, and why is whole exome sequencing based on hot spot panels preferred in the setting of precision oncology practice? (Korean)

How do the capabilities of NGS compare to hot spot testing, and why is whole exome sequencing based on hot spot panels preferred in the setting of precision oncology practice?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Byoung Chul Cho, MD, PhD

Professor Byoung Chul Cho, MD, PhD

Yonsei Cancer Center Yonsei University College of Medicine J JE-UK Laboratory of Molecular Cancer Therapeutics Seoul, Korea